Home Gilead lifted by $3.6B 1Q sales of newest hepatitis C pill
 

Keywords :   


Gilead lifted by $3.6B 1Q sales of newest hepatitis C pill

2015-05-01 02:36:04| Biotech - Topix.net

Gilead Sciences raked in $3.6 billion from sales of its newest hepatitis C pill, lifting the drugmaker's results past Wall Street expectations. Meanwhile, sales of Gilead's previous hepatitis C drug, Sovaldi, dropped 57 percent to $972 million.

Tags: c sales newest pill

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Mortgage rates hitting affordability - Nationwide
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 10A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Storm Chris Graphics
01.07Tropical Storm Chris Public Advisory Number 2A
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
More »